James Cox is the visionary CEO and Founder of BioTalent, a company he launched in 2018 to revolutionise STEM recruitment. With a passion for science, sales, and connecting exceptional talent with pioneering organisations, James has led BioTalent to become a trusted partner in the life sciences sector. His leadership is defined by a commitment to innovation, excellence, and fostering growth within the global STEM landscape.
Before founding BioTalent, James honed his expertise at Hobson Prior, where he achieved record-breaking permanent billings and played a pivotal role in expanding the Acacium Group's global footprint. In 2023, James spearheaded BioTalent’s acquisition by The IN Group, creating a global specialist division with over 60 experts dedicated to solving the talent shortage in life sciences.
Outside of work, James cherishes time with his wife and two young children. A sports enthusiast, he’s often found on the tennis court, skiing down mountains, or capturing moments as a passionate amateur photographer - a craft he once pursued professionally, with his work featured in Red Bull publications and F1 events.
Blogs by James
BioTalent launches Advisory Board to shape the future of life sciences talent
BioTalent, has launched an Advisory Board, bringing together senior leaders from across biotech, pharma services, MedTech and life sciences investment.
Why the seed funding slowdown is a talent problem, not just a funding one.
Seed funding in life sciences is down 44% year on year, and BioTalent explains why that funding gap points to a hiring gap a few years out.
The biotech market is back. The early-stage ecosystem isn't
BioTalent CEO James Cox analyses 14 months of biopharma financing data, revealing a widening gap between late-stage capital and early-stage funding.
NPS Score
70+ is considered world-class
76
Get in touch
Whether you're hiring or job hunting, we're here to make the process simple. Reach out and let's talk.
All Rights Reserved 2026 BioTalent
